IL6 and type 1 diabetes mellitus: A study conducted in Poland in a group of 71 children (aged 7–17) with type 1 diabetes demonstrated that from the first years of the disease, elevated concentrations of inflammation markers (hsCRP, IL-6, IL-1) could be observed compared to healthy children [75].